GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » NonCurrent Deferred Liabilities

Aptorum Group (Aptorum Group) NonCurrent Deferred Liabilities : $0.00 Mil (As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Aptorum Group's non-current deferred liabilities for the quarter that ended in Jun. 2023 was $0.00 Mil.

Aptorum Group NonCurrent Deferred Liabilities Historical Data

The historical data trend for Aptorum Group's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group NonCurrent Deferred Liabilities Chart

Aptorum Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial - - - - -

Aptorum Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aptorum Group NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Aptorum Group's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptorum Group (Aptorum Group) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » NonCurrent Deferred Liabilities
Comparable Companies
CYCC LIPO IBIO TRVN ERNA THER KTTA BCLI CING BTAX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
17 Hanover Square, London, GBR, W1S 1BN
Website
https://www.aptorumgroup.com
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.